Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FMTX

Forma Therapeutics (FMTX) Stock Price, News & Analysis

Forma Therapeutics logo

About Forma Therapeutics Stock (NASDAQ:FMTX)

Advanced Chart

Key Stats

Today's Range
$20.01
$20.01
50-Day Range
$19.91
$20.01
52-Week Range
$4.95
$20.68
Volume
1 shs
Average Volume
847,595 shs
Market Capitalization
$957.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forma Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FMTX Stock News Headlines

Forma Therapeutics Holdings, Inc. (FMTX)
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
4 Analysts Have This to Say About Forma Therapeutics Hldgs
Forma Therapeutics: Rare Disease Play
Novo Nordisk To Acquire Forma Therapeutics - Quick Facts
See More Headlines

FMTX Stock Analysis - Frequently Asked Questions

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) posted its quarterly earnings results on Friday, November, 12th. The company reported ($0.91) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.96) by $0.05.

Forma Therapeutics (FMTX) raised $201 million in an initial public offering (IPO) on Friday, June 19th 2020. The company issued 11,800,000 shares at a price of $16.00-$18.00 per share. Jefferies' SVB Leerink and Credit Suisse served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Forma Therapeutics investors own include Tesla (TSLA), HubSpot (HUBS), Cheniere Energy (LNG), Netflix (NFLX), Marvell Technology (MRVL) and Viper Energy (VNOM).

Company Calendar

Last Earnings
11/12/2021
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:FMTX
CIK
1538927
Fax
N/A
Employees
166
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$172.96 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-39.68%
Return on Assets
-35.33%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.74
Quick Ratio
12.74

Sales & Book Value

Annual Sales
$100.56 million
Price / Sales
9.52
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.51 per share
Price / Book
1.90

Miscellaneous

Outstanding Shares
47,853,000
Free Float
45,082,000
Market Cap
$957.54 million
Optionable
Not Optionable
Beta
-0.94

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:FMTX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners